Maruyama Noriaki | Division Of Nephrology Hypertension And Endocrinology Department Of Medicine Nihon University School
スポンサーリンク
概要
- 同名の論文著者
- Division Of Nephrology Hypertension And Endocrinology Department Of Medicine Nihon University Schoolの論文著者
関連著者
-
Okada Kazuyoshi
Division of Nephrology and Endocrinology, Department of Medicine, Nihon University School of Medicin
-
Okada Kazuyoshi
日本大学 医学部腎臓高血圧内分泌内科学
-
Okada Kazuyoshi
Division Of Nephrology Hypertension And Endocrinology Department Of Medicine Nihon University School
-
Abe Masanori
Division Of Nephrology Hypertension And Endocrinology Department Of Medicine Nihon University School
-
Maruyama Noriaki
Division Of Nephrology Hypertension And Endocrinology Department Of Medicine Nihon University School
-
Abe Masanori
Division Of Nephrology Hypertension And Endocrinology Department Of Internal Medicine Nihon Universi
-
Maruyama Noriaki
Division Of Nephrology Hypertension And Endocrinology Department Of Internal Medicine Nihon Universi
-
Matsumoto Koichi
日本大学 医学部内科学系腎臓高血圧内分泌内科
-
Matsumoto K
Division Of Nephrology Hypertension And Endocrinology Department Of Medicine Nihon University School
-
Matsumoto Koichi
Division Of Nephrology Hypertension And Endocrinology Department Of Medicine Nihon University School
著作論文
- Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease
- A case of femoral hemorrhage in a patient with microscopic polyangiitis with low levels of myeloperoxidase-antineutrophil cytoplasmic autoantibody
- Efficacy analysis of the lipid-lowering and renoprotective effects of rosuvastatin in patients with chronic kidney disease
- Efficacy and safety and mitiglinide in diabetic patients on maintenance hemodialysis
- Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria
- The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis